Serum CA125 as a biomarker for dysmenorrhea in adenomyosis
Serum CA125 levels are elevated in adenomyosis patients experiencing dysmenorrhea, with a cut-point of 35 U/mL identifying dysmenorrhea and correlating positively with lesion volume and negatively with age.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood (2-hop)
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. Outer rings show 2-hop neighbours — papers reached through the immediate citers/citees. [ collapse to 1-hop ]
References (34)
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- Combined therapeutic effects of HIFU, GnRH-a and LNG-IUS for the treatment of severe adenomyosis via openalex
- Diagnosing adenomyosis: an integrated clinical and imaging approach via openalex
- Epidemiology of Adenomyosis via openalex
- Estrogen degrades Scribble in endometrial epithelial cells through E3 ubiquitin ligase HECW1 in the development of diffuse adenomyosis† via openalex
- Expression of Inflammatory and Neurogenic Mediators in Adenomyosis via openalex
- Gonadotrophin-releasing hormone agonist combined with high-intensity focused ultrasound ablation for adenomyosis: a clinical study via openalex
- Immunological changes associated with adenomyosis: a systematic review via openalex
- MRI for adenomyosis: a pictorial review via openalex
- Possible involvement of neuropeptide and neurotransmitter receptors in Adenomyosis via openalex
- Relationship between Cyst Fluid Concentrations of Iron and Severity of Dysmenorrhea in Patients with Ovarian Endometrioma via openalex
- Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis via openalex
- Severe adenomyosis and CA125 via openalex
- Usefulness of CA125 in the differential diagnosis of uterine adenomyosis and myoma via openalex
- Uterine adenomyosis and adenomyoma: the surgical approach via openalex
- W6659946320 via openalex
- W6783937282 via openalex
- W6784688324 via openalex
- W1978393091 via openalex
- W7074078212 via openalex
- W1992451410 via openalex
- W1998812648 via openalex
- W2001866306 via openalex
- W2038396848 via openalex
- W2503974089 via openalex
- W2785096045 via openalex
- W2897457508 via openalex
- W2925925144 via openalex
- W2989384704 via openalex
- W3030082703 via openalex
- W3101128243 via openalex
- W3213017321 via openalex
- W6647489417 via openalex
- W6650896577 via openalex
Cited by (15)
- Identification of diagnostic blood indicators associated with adenomyosis: a retrospective cohort study 2026
- Regional homogeneity alterations reflect pain and emotional dysregulation in adenomyosis 2026
- Development and validation of a nomogram to predict symptomatic recurrence following laparoscopic adenomyomectomy 2026
- Microwave ablation of adenomyosis: five-year follow-up and risk factors for recurrence of symptoms 2026
- High-intensity focused ultrasound combined with syndrome differentiation-based individualized herbal therapy and 12-month outcomes in patients with adenomyosis: a prospective non-randomized study 2026
- Clinical outcomes of uterine artery embolization in different Kishi classification types of adenomyosis 2026
- Deciphering the Pain-Related Gut Microbiome in Patients With Endometriosis 2025
- Comparison of safety and efficacy of hysteroscopic LNG-IUS fixation surgery and conventional LNG-IUS placement in the treatment of adenomyosis: A retrospective cohort study 2025
- The etiology differs regards to the locations of the lesion: a clinical experience of 1350 patients with adenomyosis confirmed by postoperative pathology 2025
- Validation of an in vitro diagnostic test for endometriosis: impact of confounding medical conditions and lesion location 2024
- Comprehensive analysis of circRNA-miRNA-mRNA regulatory network and novel potential biomarkers in eutopic endometrium of adenomyosis 2024
- Comprehensive analysis of circRNA-miRNA-mRNA regulatory network and novel potential biomarkers in eutopic endometrium of adenomyosis 2024
- Cytotoxic T Lymphocytes, Tc17 Cells, Th1 Cells, and ThGM Cells are Increased in the Blood and Ectopic Endometrium of Patients With Adenomyosis 2024
- Validation of an In Vitro Diagnostic Test for Endometriosis: Impact of Confounding Medical Conditions and Lesion Location 2024
- Magnetic resonance imaging-based Classification criteria combined with Serum CA125 for dysmenorrhea before focused ultrasound ablation surgery in adenomyosis 2024
Source provenance
- europepmc
- last seen: 2026-10-14T06:08:39.101224+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-10-14T06:08:00.033488+00:00
- unpaywall
- last seen: 2026-10-14T06:23:58.021457+00:00